Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2015 Dec 23;25(2):351–358. doi: 10.1158/1055-9965.EPI-15-0983

Table 3.

Associations of Demographic and Clinical Characteristics with 2nd Dose of HPV Vaccine by Age Group Among 1,834 Males Attending JHCP Clinics from 2012–2013

Target (11–12 years) Catch-Up (13–21 years)

2nd Dose HPV
Vaccine
2nd Dose HPV
Vaccine

Yes
(n=261)
No
(n=232)
aOR
(95% CI)
Yes
(n=603)
No
(n=667)
aOR
(95% CI)
Mean Baseline Age (SD) 11.43
(0.5)
11.46
(0.5)
0.86
(0.65 – 1.13)
15.55
(2.1)
15.97
(2.2)
0.95
(0.88 – 1.02)
Race/Ethnicity n
White 104 43 1.0
(Reference)
257 147 1.0
(Reference)
Black 132 160 0.63
(0.40 – 1.00)
283 458 0.65
(0.46 – 0.92)
Hispanic 8 10 0.39
(0.17 – 0.89)
21 23 0.72
(0.33 – 1.54)
Asian 6 4 0.50
(0.17 – 1.46)
10 7 1.11
(0.52 – 2.40)
Other 11 15 0.26
(0.09 – 0.81)
32 32 0.71
(0.37 – 1.37)
Insurance Type n
Private 100 61 1.0
(Reference)
266 230 1.0
(Reference)
Public 104 142 0.77
(0.43 – 1.39)
195 347 0.73
(0.56 – 0.96)
Military 57 29 1.03
(0.60 – 1.79)
138 86 0.78
(0.52 – 1.16)
Number of Clinic Visits n
1–3 Visits 136 194 1.0
(Reference)
326 596 1.0
(Reference)
>3 Visits 125 38 4.01
(3.22 – 4.99)
277 71 5.82
(4.13 – 8.20)
JHCP Clinic Location n
Suburban 149 89 1.0
(Reference)
374 273 1.0
(Reference)
Urban 112 143 1.08
(0.35 – 3.34)
229 394 0.77
(0.46 – 1.31)
JHCP Specialty n
Family Practice 64 37 1.0
(Reference)
205 149 1.0
(Reference)
IM/Peds 19 13 0.63
(0.34 – 1.19)
32 44 0.52
(0.28 – 0.97)
Internal Med 0 3 1.00
(1.00 – 1.00)
17 28 0.65
(0.31 – 1.40)
Pediatrics 178 179 0.57
(0.30 – 1.06)
349 446 1.07
(0.74 – 1.54)

All models mutually adjusted for all variables listed in the table. Results for the permissive age group are not shown due to limited statistical power

Abbreviations: aOR – Adjusted Odds Ratio; CI, Confidence Interval; Asian/Pacific Is., Asian/Pacific Islander; IM/Peds, Internal Medicine/Pediatrics; Internal Med, Internal Medicine